Literature DB >> 33065292

Medicinal chemistry perspective of TRPM2 channel inhibitors: where we are and where we might be heading?

Han Zhang1, Siqi Zhao1, Jie Yu1, Wei Yang2, Zhenming Liu3, Liangren Zhang4.   

Abstract

Transient receptor potential melastatin 2 (TRPM2) is a Ca2+- permeable nonselective cation channel that is involved in diverse biological functions as a cellular sensor for oxidative stress and temperature. It has been considered a promising therapeutic target for the treatment of ischemia/reperfusion (IR) injury, inflammation, cancer, and neurodegenerative diseases. Development of highly potent and selective TRPM2 inhibitors and validation of their use in relevant disease models will advance drug discovery. In this review, we describe the molecular structures and gating mechanism of the TRPM2 channel, and offer a comprehensive review of advances in the discovery of TRPM2 inhibitors. Furthermore, we analyze the properties of reported TRPM2 inhibitors with an emphasis on how specific inhibitors targeting this channel could be better developed.
Copyright © 2020 Elsevier Ltd. All rights reserved.

Entities:  

Year:  2020        PMID: 33065292     DOI: 10.1016/j.drudis.2020.09.039

Source DB:  PubMed          Journal:  Drug Discov Today        ISSN: 1359-6446            Impact factor:   7.851


  2 in total

Review 1.  TRP channels: a journey towards a molecular understanding of pain.

Authors:  Tamara Rosenbaum; Sara L Morales-Lázaro; León D Islas
Journal:  Nat Rev Neurosci       Date:  2022-07-13       Impact factor: 38.755

2.  Endothelial and Vascular Health: A Tale of Honey, H2O2 and Calcium.

Authors:  Elia Ranzato; Gregorio Bonsignore; Mauro Patrone; Simona Martinotti
Journal:  Cells       Date:  2021-04-30       Impact factor: 6.600

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.